These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7504662)

  • 1. Association of Ulex europaeus agglutinin I binding with invasion in endometrial carcinoma.
    Ambros RA; Kurman RJ
    Int J Gynecol Pathol; 1993 Oct; 12(4):301-6. PubMed ID: 7504662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of lectin binding for prognosis in endometrial carcinoma.
    Ookuma Y; Hachisuga T; Iwasaka T; Sugimori H
    Pathology; 1994 Jul; 26(3):225-9. PubMed ID: 7991274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-binding patterns in normal, hyperplastic and neoplastic endometrium: the prognostic value of concanavalin A.
    Sivridis E; Giatromanolaki A; Koukourakis M; Agnantis N
    Virchows Arch; 2000 Jan; 436(1):52-8. PubMed ID: 10664162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.
    Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y
    Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
    Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
    Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in lectin binding patterns of normal endometrium and endometrial adenocarcinoma, with special reference to staining with Ulex europeus agglutinin 1 and peanut agglutinin.
    Aoki D; Nozawa S; Iizuka R; Kawakami H; Hirano H
    Gynecol Oncol; 1990 Jun; 37(3):338-45. PubMed ID: 1693583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
    Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
    Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
    Shroyer KR; Stephens JK; Silverberg SG; Markham N; Shroyer AL; Wilson ML; Enomoto T
    Int J Gynecol Pathol; 1997 Jul; 16(3):225-32. PubMed ID: 9421087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
    Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium.
    Mai KT; Yazdi HM; Boone SA
    Arch Pathol Lab Med; 1995 Aug; 119(8):751-4. PubMed ID: 7544107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
    Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
    J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
    Liang S; Huang C; Jia S; Wang B
    Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia?
    Sivridis E; Giatromanolaki A; Liberis V; Koukourakis MI
    Autophagy; 2011 Jan; 7(1):74-82. PubMed ID: 21099253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
    Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
    Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
    Srodon M; Klein WM; Kurman RJ
    Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.